Mesa Laboratories, Inc. announced that it will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on May 31, 2024. Mesa?s Form 10-K will be filed the same day. The earnings announcement has been delayed as the company finalize the calculations and technical accounting for previously-announced impairments of long-lived assets and goodwill related to Clinical Genomics and Biopharmaceutical Development divisions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
91.28 USD | -0.43% | -4.34% | -12.88% |
06-05 | Earnings Flash (MLAB) MESA LABORATORIES Posts Q4 Revenue $58.9M, vs. Street Est of $55.3M | MT |
06-05 | Earnings Flash (MLAB) MESA LABORATORIES Posts Q4 EPS $2.77, vs. Street Est of $1.75 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.88% | 492M | |
-5.52% | 181B | |
-3.19% | 105B | |
-4.14% | 67.55B | |
-6.00% | 46.39B | |
+4.82% | 40.93B | |
+22.10% | 31.63B | |
+12.18% | 24.28B | |
-8.53% | 23.46B | |
-12.33% | 21.95B |
- Stock Market
- Equities
- MLAB Stock
- News Mesa Laboratories, Inc.
- Mesa Laboratories, Inc. Delays Earnings Announcement for the Fourth Quarter and Full Fiscal Year 2024 Results